Traws Pharma, Inc. SEC filings TRAW
Traws Pharma, Inc. has 988 filings in SEC EDGAR's recent list, going back to Jan 8, 2003. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 9, 2026 | — |
| CORRESP | Letter to the SEC | Jul 7, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2026 | — |
| EFFECT | Filing | May 15, 2026 | — |
| CORRESP | Letter to the SEC | May 13, 2026 | — |
| UPLOAD | Letter from the SEC | May 12, 2026 | — |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Jan 22, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2025 | — |
| EFFECT | Filing | Aug 28, 2024 | — |
| CORRESP | Letter to the SEC | Aug 26, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2024 | — |
| CORRESP | Letter to the SEC | Aug 16, 2024 | — |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| CORRESP | Letter to the SEC | Jul 30, 2024 | — |
| PRER14A | Filing | Jul 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| D | Filing | Apr 16, 2024 | — |
| EFFECT | Filing | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2023 | — |
| 25-NSE | Delisting notice | Jul 23, 2021 | — |
| EFFECT | Filing | May 18, 2020 | — |
| CORRESP | Letter to the SEC | May 15, 2020 | — |
| CORRESP | Letter to the SEC | May 15, 2020 | — |
| UPLOAD | Letter from the SEC | May 7, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 19, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 7, 2020 | — |
| EFFECT | Filing | Nov 21, 2019 | — |
| CORRESP | Letter to the SEC | Nov 21, 2019 | — |
| CORRESP | Letter to the SEC | Nov 21, 2019 | — |
| CORRESP | Letter to the SEC | Nov 20, 2019 | — |
| CORRESP | Letter to the SEC | Nov 20, 2019 | — |
| CORRESP | Letter to the SEC | Nov 13, 2019 | — |
| CORRESP | Letter to the SEC | Nov 13, 2019 | — |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2019 | — |
| D | Filing | Jun 4, 2019 | — |
| EFFECT | Filing | May 21, 2019 | — |
| CORRESP | Letter to the SEC | May 17, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2019 | — |
| D | Filing | Jun 8, 2018 | — |
| CT ORDER | Filing | Jun 6, 2018 | — |
| EFFECT | Filing | Apr 26, 2018 | — |
| CORRESP | Letter to the SEC | Apr 26, 2018 | — |
| CORRESP | Letter to the SEC | Apr 26, 2018 | — |
| CORRESP | Letter to the SEC | Apr 25, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2018 | — |
| EFFECT | Filing | Feb 7, 2018 | — |
| CORRESP | Letter to the SEC | Feb 6, 2018 | — |
| CORRESP | Letter to the SEC | Feb 6, 2018 | — |
| CORRESP | Letter to the SEC | Jan 30, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2018 | — |
| EFFECT | Filing | Dec 28, 2017 | — |
| CORRESP | Letter to the SEC | Dec 27, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2017 | — |
| CERTNAS | Auto-generated paper document | Aug 2, 2016 | — |
| 8-A12B | Filing | Jul 27, 2016 | — |
| EFFECT | Filing | Jul 7, 2016 | — |
| CORRESP | Letter to the SEC | Jul 5, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2016 | — |
| EFFECT | Filing | Apr 28, 2016 | — |
| CORRESP | Letter to the SEC | Apr 25, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2016 | — |
| EFFECT | Filing | Nov 3, 2015 | — |
| CORRESP | Letter to the SEC | Nov 2, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2015 | — |
| D | Filing | Oct 23, 2015 | — |
| EFFECT | Filing | Nov 20, 2014 | — |
| CT ORDER | Filing | Jul 29, 2013 | — |
| EFFECT | Filing | Jul 24, 2013 | — |
| CERTNAS | Auto-generated paper document | Jul 23, 2013 | — |
| CORRESP | Letter to the SEC | Jul 23, 2013 | — |
| CORRESP | Letter to the SEC | Jul 23, 2013 | — |
| 8-A12B | Filing | Jul 23, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2013 | — |
| UPLOAD | Letter from the SEC | May 30, 2013 | — |
| DRS | Filing | May 3, 2013 | — |
| D | Filing | Aug 13, 2012 | — |
| D/A | Filing | Jul 26, 2012 | — |
| D | Filing | May 10, 2012 | — |
| D/A | Filing | Jan 5, 2011 | — |
| D | Filing | Oct 4, 2010 | — |
| D/A | Filing | Mar 4, 2010 | — |
| D | Filing | May 26, 2009 | — |
| REGDEX/A | Auto-generated paper document | Sep 14, 2007 | — |
| REGDEX | Auto-generated paper document | May 30, 2007 | — |
| REGDEX/A | Auto-generated paper document | Nov 13, 2006 | — |
| REGDEX/A | Auto-generated paper document | Dec 23, 2005 | — |
| REGDEX/A | Auto-generated paper document | Dec 20, 2005 | — |
| REGDEX | Auto-generated paper document | Apr 1, 2005 | — |
| REGDEX/A | Auto-generated paper document | Jul 28, 2004 | — |
| REGDEX | Auto-generated paper document | Apr 1, 2004 | — |
| REGDEX | Auto-generated paper document | Dec 4, 2003 | — |
| REGDEX/A | Auto-generated paper document | Jun 3, 2003 | — |
| REGDEX/A | Auto-generated paper document | May 19, 2003 | — |
| REGDEX | Auto-generated paper document | Jan 8, 2003 | — |
Showing 101 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newtown, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1130598
- Former names
- Onconova Therapeutics, Inc. (until Apr 1, 2024); ONCONOVA THERAPEUTICS INC (until May 26, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.